ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial

Recruiting

Phase 3

Hunger EliminationARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial

Sponsor:

Aardvark Therapeutics, Inc.

Code:

NCT06828861

Conditions

Hyperphagia

Prader-Willi Syndrome

Eligibility Criteria

Sex: All

Age: 7+

Healthy Volunteers: Not accepted

Interventions

Placebo

ARD-101

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-03. This information was provided to ClinicalTrials.gov by Aardvark Therapeutics, Inc. on 2026-02-12.